DNA Microviscosity Converts Ruthenium Polypyridyl Complexes to Effective Photosensitizers

31 January 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A unique radiative decay engineering strategy using DNA microviscosity for the generation of ruthenium polypyridyl complex (RPCs) mediated singlet oxygen for selective damage of DNA and killing cancer cells is reported. This investigation also demonstarte the effect of light-driven RPCs on bacterial growth arrest, through DNA nick, and differential localization in cancer and non-cancer cells. Moreover, upon binding with DNA, RPCs experience high local microviscosity, which causes significant enhancement of the excited state lifetime and thus generates singlet oxygen. The visible-light-triggered singlet-oxygen efficiently produce nick in DNA and inhibits bacterial growth. RPCs also localize inside the nucleus of the cancer cell and in the vicinity of the nuclear membrane of non-cancerous cells, confirmed by live-cell confocal microscopy. The results provide a facile platform for the novel antibiotic intended discovery combined with cancer therapy.

Keywords

Iridium complex
DNA Microviscosity
Reactive oxygen species
anticancer drugs
photosensitizers

Supplementary materials

Title
Description
Actions
Title
1 0001 00000
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.